Cargando…
Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression
BACKGROUND: Existing research evidence indicates that breast cancer patients have different degrees of cognitive dysfunction after chemotherapy, and polymorphisms in 3 genes (catechol-O-methyltransferase, COMT; apolipoprotein E, APOE; and brain-derived neurotrophic factor, BDNF) have been associated...
Autores principales: | Li, Wen, Zhao, Jingjing, Ding, Ke, Chao, Herta H., Li, Chiang-Shan R., Cheng, Huaidong, Shen, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531203/ https://www.ncbi.nlm.nih.gov/pubmed/32985495 http://dx.doi.org/10.12659/MSM.923567 |
Ejemplares similares
-
Depression involved in self-reported prospective memory problems in survivors of breast cancer who have received chemotherapy
por: Huang, Zhonglian, et al.
Publicado: (2019) -
Genetics of headache and catechol–O–methyltransferase gene polymorphism
por: Bayazit, Yildirim A.
Publicado: (2006) -
Catechol-O-methyltransferase (COMT) polymorphisms modulate working memory in individuals with schizophrenia and healthy controls
por: Matsuzaka, Camila T., et al.
Publicado: (2017) -
Polymorphism of the catechol-O-methyltransferase gene in Han Chinese patients with psoriasis vulgaris
por: Gao, Lin, et al.
Publicado: (2009) -
Genetic Contribution of Catechol-O-methyltransferase Polymorphism in Patients with Migraine without Aura
por: Park, Jeong Wook, et al.
Publicado: (2007)